Faster, cheaper, and less invasive—this new test can detect thousands of rare genetic disorders using just one sample.

The expression of symptoms of viral infections is a byproduct of complex virus-host molecular pathways. These remain largely ...

Shuttle-based therapies are under active development for an array of brain conditions. “It’s now abundantly clear that we can ...

One of these enzymes, named VEnT1.3 ... the power of combining cutting-edge science from different fields—genetic engineering, chemistry, and biology—to solve practical problems.

Explore key trends, drivers, and growth forecasts shaping the global reverse transcriptase enzymes market from 2022 to 2032 North America remains at the forefront of the Reverse Transcriptase ...

Mycetoma is a chronic and progressively debilitating disease that affects thousands of people living in tropical and ...

Genetic engineering is the act of modifying the genetic ... of transmission dynamics that shape microbiomes. The human ADAR enzyme can deaminate additional transcripts for therapeutic A-to-G ...

The proteinase k market is expected to reach approximately USD 30.2 million in 2025 and expand to around USD 48.2 million by 2035, reflecting a compound annual growth rate (CAGR) of 4.8% over the ...

The molecular pathways involved in antiviral defenses and counter-defenses in host-pathogen systems remain unclear. Researchers have used Neurospora crassa as a model organism to explore how RNA ...

Mycetoma, a devastating neglected tropical disease, often resists standard treatment with itraconazole when caused by the ...

A baby known as KJ is the first person in the world to receive a customized CRISPR therapy designed to fix a specific ...